Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Jul. 30, 2016	Apr. 30, 2016	Aug. 01, 2015	May 02, 2015	Jul. 30, 2016	Aug. 01, 2015
Net Cash Provided by Operating Activities					$ 421	$ 375
Investing Activities:
Capital Expenditures					(497)	(358)
Proceeds from Sale of Other Assets, Investing Activities					0	135
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital					108	0
Proceeds from Sale of Equity Method Investments					0	85
Proceeds from Sale and Maturity of Marketable Securities					10	0
Investment In Equity Affiliates					0
Payments to Acquire Businesses, Net of Cash Acquired					(31)	0
Payments to Acquire Marketable Securities					0	(50)
Other Investing Activities					16	1
Net Cash Provided by (Used for) Investing Activities					(394)	(187)
Financing Activities:
Proceeds from Debt, Net of Issuance Costs					692	0
Repayments of Long-term Debt					(742)	0
Proceeds from Long-term Lines of Credit					10	0
Repurchases of Common Stock					(385)	(295)
Dividends Paid	$ (173)	$ (750)	$ (146)	$ (734)	(923)	(880)
Excess Tax Benefits from Share-based Compensation					37	61
Net Financing Activities and Advances to/from Consolidated Affiliates					0	0
Proceeds from Exercise of Stock Options					13	23
Proceeds from (Payments for) Other Financing Activities					(1)	0
Net Cash Provided by (Used for) Financing Activities					(1,299)	(1,091)
Effects of Exchange Rate Changes on Cash and Cash Equivalents					(3)	2
Net Increase (Decrease) in Cash and Cash Equivalents					(1,275)	(901)
Cash and Cash Equivalents, Beginning of Period		2,548		1,681	2,548	1,681
Cash and Cash Equivalents, End of Period	1,273		780		1,273	780
L Brands, Inc.
Net Cash Provided by Operating Activities					(258)	(147)
Investing Activities:
Capital Expenditures					0	0
Proceeds from Sale of Other Assets, Investing Activities						0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital					0
Proceeds from Sale of Equity Method Investments						0
Proceeds from Sale and Maturity of Marketable Securities					0
Investment In Equity Affiliates					0
Payments to Acquire Businesses, Net of Cash Acquired					0
Payments to Acquire Marketable Securities						0
Other Investing Activities					0	0
Net Cash Provided by (Used for) Investing Activities					0	0
Financing Activities:
Proceeds from Debt, Net of Issuance Costs					692
Repayments of Long-term Debt					(742)
Proceeds from Long-term Lines of Credit					0
Repurchases of Common Stock					(385)	(295)
Dividends Paid					(923)	(880)
Excess Tax Benefits from Share-based Compensation					0	0
Net Financing Activities and Advances to/from Consolidated Affiliates					1,603	1,299
Proceeds from Exercise of Stock Options					13	23
Proceeds from (Payments for) Other Financing Activities					0
Net Cash Provided by (Used for) Financing Activities					258	147
Effects of Exchange Rate Changes on Cash and Cash Equivalents					0	0
Net Increase (Decrease) in Cash and Cash Equivalents					0	0
Cash and Cash Equivalents, Beginning of Period		0		0	0	0
Cash and Cash Equivalents, End of Period	0		0		0	0
Guarantor Subsidiaries
Net Cash Provided by Operating Activities					490	481
Investing Activities:
Capital Expenditures					(382)	(254)
Proceeds from Sale of Other Assets, Investing Activities						0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital					0
Proceeds from Sale of Equity Method Investments						1
Proceeds from Sale and Maturity of Marketable Securities					0
Investment In Equity Affiliates					0
Payments to Acquire Businesses, Net of Cash Acquired					0
Payments to Acquire Marketable Securities						(50)
Other Investing Activities					1	0
Net Cash Provided by (Used for) Investing Activities					(381)	(303)
Financing Activities:
Proceeds from Debt, Net of Issuance Costs					0
Repayments of Long-term Debt					0
Proceeds from Long-term Lines of Credit					0
Repurchases of Common Stock					0	0
Dividends Paid					0	0
Excess Tax Benefits from Share-based Compensation					33	53
Net Financing Activities and Advances to/from Consolidated Affiliates					(1,441)	(1,240)
Proceeds from Exercise of Stock Options					0	0
Proceeds from (Payments for) Other Financing Activities					(1)
Net Cash Provided by (Used for) Financing Activities					(1,409)	(1,187)
Effects of Exchange Rate Changes on Cash and Cash Equivalents					0	0
Net Increase (Decrease) in Cash and Cash Equivalents					(1,300)	(1,009)
Cash and Cash Equivalents, Beginning of Period		2,190		1,462	2,190	1,462
Cash and Cash Equivalents, End of Period	890		453		890	453
Non- guarantor Subsidiaries
Net Cash Provided by Operating Activities					189	41
Investing Activities:
Capital Expenditures					(115)	(104)
Proceeds from Sale of Other Assets, Investing Activities						135
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital					108
Proceeds from Sale of Equity Method Investments						84
Proceeds from Sale and Maturity of Marketable Securities					10
Investment In Equity Affiliates					(38)
Payments to Acquire Businesses, Net of Cash Acquired					(31)
Payments to Acquire Marketable Securities						0
Other Investing Activities					15	1
Net Cash Provided by (Used for) Investing Activities					(51)	116
Financing Activities:
Proceeds from Debt, Net of Issuance Costs					0
Repayments of Long-term Debt					0
Proceeds from Long-term Lines of Credit					10
Repurchases of Common Stock					0	0
Dividends Paid					0	0
Excess Tax Benefits from Share-based Compensation					4	8
Net Financing Activities and Advances to/from Consolidated Affiliates					(124)	(59)
Proceeds from Exercise of Stock Options					0	0
Proceeds from (Payments for) Other Financing Activities					0
Net Cash Provided by (Used for) Financing Activities					(110)	(51)
Effects of Exchange Rate Changes on Cash and Cash Equivalents					(3)	2
Net Increase (Decrease) in Cash and Cash Equivalents					25	108
Cash and Cash Equivalents, Beginning of Period		358		219	358	219
Cash and Cash Equivalents, End of Period	383		327		383	327
Eliminations
Net Cash Provided by Operating Activities					0	0
Investing Activities:
Capital Expenditures					0	0
Proceeds from Sale of Other Assets, Investing Activities						0
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital					0
Proceeds from Sale of Equity Method Investments						0
Proceeds from Sale and Maturity of Marketable Securities					0
Investment In Equity Affiliates					38
Payments to Acquire Businesses, Net of Cash Acquired					0
Payments to Acquire Marketable Securities						0
Other Investing Activities					0	0
Net Cash Provided by (Used for) Investing Activities					38	0
Financing Activities:
Proceeds from Debt, Net of Issuance Costs					0
Repayments of Long-term Debt					0
Proceeds from Long-term Lines of Credit					0
Repurchases of Common Stock					0	0
Dividends Paid					0	0
Excess Tax Benefits from Share-based Compensation					0	0
Net Financing Activities and Advances to/from Consolidated Affiliates					(38)	0
Proceeds from Exercise of Stock Options					0	0
Proceeds from (Payments for) Other Financing Activities					0
Net Cash Provided by (Used for) Financing Activities					(38)	0
Effects of Exchange Rate Changes on Cash and Cash Equivalents					0	0
Net Increase (Decrease) in Cash and Cash Equivalents					0	0
Cash and Cash Equivalents, Beginning of Period		$ 0		$ 0	0	0
Cash and Cash Equivalents, End of Period	$ 0		$ 0		$ 0	$ 0